Swinney D C, Webb A S, Freedman R
Department of Drug Metabolism, Syntex Research, Palo Alto, CA 94304.
Biochem Pharmacol. 1991 Nov 27;42(12):2341-9. doi: 10.1016/0006-2952(91)90239-2.
2-Methoxy-6-[1-methylethyl]naphthalene (MMEN) was hydroxylated in an NADPH-dependent manner to the (omega-1)-alcohol and the (R)-omega- and (S)-omega-alcohols by rat hepatic microsomes. (S)-omega-Hydroxylation was selectively induced 7-fold by clofibrate treatment. Phenobarbital, 3-methyl-cholanthrene, dexamethasone, cholestyramine, and MMEN did not induce this activity to the same extent. Incubation of the racemic omega-alcohols with microsomes isolated from rats resulted in a greater rate of degradation of the (S)- than the (R)-omega-alcohol confirming (S)-omega-hydroxylation to be an initial catalytic event. MMEN and lauric acid were not competitive inhibitors of each other in microsomes from clofibrate-treated rats, indicating the (S)-omega-MMEN hydroxylase to be a different enzyme from the characterized clofibrate-inducible lauric acid hydroxylases, CYP4A1 and CYP4A3. This was confirmed by the observations that (1) lauric acid hydroxylation was inhibited by 0.02% Tween 20 or Tween 80 and 25 microM capric or myristic acids, whereas omega-MMEN hydroxylation was not, (2) omega-MMEN hydroxylation was inhibited by ketoconazole, cholesterol and acetone, whereas lauric acid hydroxylation was not, and (3) CYP4A1 and CYP4A3 expressed in Hep G2 cells did not catalyze MMEN hydroxylation. Microsomes from the lungs of rabbits treated with progesterone and kidney of untreated rats did not support selective (S)-omega-MMEN hydroxylation, indicating that this activity is not associated with CYP4A4 or CYP4A2, respectively. Leukotriene B4 (LTB4) hepatic microsomal hydroxylation was not inhibited by MMEN and microsomes from human neutrophils did not support the reaction. These data identify a hitherto uncharacterized cytochrome P450 which is selectively induced by clofibrate and does not catalyze the omega-hydroxylation of the fatty acids or prostaglandins investigated. It is proposed that the enzyme catalyzing the selective (S)-omega-hydroxylation of MMEN is a novel rat P450 and that it is either a new member of the CYP4 family or a clofibrate-inducible P450 from another gene family.
2-甲氧基-6-[1-甲基乙基]萘(MMEN)在大鼠肝微粒体中以NADPH依赖的方式被羟基化为(ω-1)-醇以及(R)-ω-醇和(S)-ω-醇。氯贝丁酯处理可使(S)-ω-羟基化选择性诱导7倍。苯巴比妥、3-甲基胆蒽、地塞米松、消胆胺和MMEN在相同程度上未诱导该活性。将外消旋ω-醇与从大鼠分离的微粒体一起孵育,结果显示(S)-ω-醇的降解速率比(R)-ω-醇更快,证实(S)-ω-羟基化是初始催化事件。在氯贝丁酯处理的大鼠的微粒体中,MMEN和月桂酸不是彼此的竞争性抑制剂,这表明(S)-ω-MMEN羟化酶与已鉴定的氯贝丁酯诱导型月桂酸羟化酶CYP4A1和CYP4A3是不同的酶。以下观察结果证实了这一点:(1)0.02%吐温20或吐温80以及25 microM癸酸或肉豆蔻酸可抑制月桂酸羟化,而ω-MMEN羟化不受影响;(2)酮康唑、胆固醇和丙酮可抑制ω-MMEN羟化,而月桂酸羟化不受影响;(3)在Hep G2细胞中表达的CYP4A1和CYP4A3不催化MMEN羟化。用孕酮处理的兔肺微粒体和未处理大鼠的肾微粒体不支持选择性(S)-ω-MMEN羟化,表明该活性分别与CYP4A4或CYP4A2无关。白三烯B4(LTB4)肝微粒体羟化不受MMEN抑制,人中性粒细胞微粒体不支持该反应。这些数据鉴定出一种迄今未表征的细胞色素P450,它被氯贝丁酯选择性诱导,并且不催化所研究的脂肪酸或前列腺素的ω-羟基化。有人提出,催化MMEN选择性(S)-ω-羟基化的酶是一种新型大鼠P450,它要么是CYP4家族的新成员,要么是来自另一个基因家族的氯贝丁酯诱导型P450。